title: [Optimizing treatment of type 2 diabetic patients].
authors.affiliation: , .
authors.lastname: Red
mesh_terms: D000284:Administration, Oral; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy*; D004338:Drug Combinations; D005858:Germany; D052216:Glucagon-Like Peptide 1 / Q000008:administration & dosage / Q000031:analogs & derivatives*; D006442:Glycated Hemoglobin / Q000378:metabolism; D006801:Humans; D007279:Injections, Subcutaneous; D049528:Insulin, Long-Acting / Q000008:administration & dosage*; D000069450:Liraglutide; D008687:Metformin / Q000008:administration & dosage
chemical_list: D004338:Drug Combinations; D052216:Glucagon-Like Peptide 1; D006442:Glycated Hemoglobin; D049528:Insulin, Long-Acting; D000069450:Liraglutide; D008687:Metformin; C517652:hemoglobin A1c protein, human; C571886:insulin degludec